[Current therapeutic concept of acute promyelocytic leukemia].
Lengfelder
E
E
III. Medizinische Universitätsklinik Mannheim, Universität Heidelberg, Germany.
Hehlmann
R
R
Büchner
T
T
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017209:Apoptosis; D004305:Dose-Response Relationship, Drug; D004358:Drug Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D011379:Prognosis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014178:Translocation, Genetic; D014212:Tretinoin / Q000009:adverse effects / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014212:Tretinoin
Aktuelle Therapiekonzepte bei akuter Promyelozytenleukämie.